Recurring concern
Failure to provide timely treatment for constipation and impacted faeces
- Reports that mention this concern
- 3
- Times this concern has been raised
- 3
- Stated actions linked to this concern
- 3
What this concern includes
Includes failures in the treatment process for clinically significant constipation or impacted faeces, including timely prescribing, administration, monitoring and escalation of indicated enemas, laxatives or comparable treatment.
What is not included
- Excludes bowel-monitoring or documentation failures when required constipation treatment itself was provided reliably.
- Excludes generic delays in clinical treatment where constipation or impacted faeces is not the identified condition.
- Excludes unrelated bowel conditions or treatment failures without a material constipation or faecal-impaction component.
- Excludes failures occurring after appropriate constipation treatment has been provided when the remaining concern is solely follow-up or another downstream process.
Trends
Reports over time
Reports mentioning this concern, over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Reports and published responses 3 reports
See individual reports that have raised this concern, and the actions taken in response
-
Concerns raised1
Delays in managing clozapine constipation
This report raised 7 other concerns. They are not shown here because they do not form part of this recurring concern.
Linked response
- Essex Partnership University NHS Foundation Trust
Stated actions An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.2
-
Essex Partnership University NHS Foundation Trust
Disseminate the January 2025 updated clozapine policy across medical teams to strengthen constipation assessment, monitoring and documentation.
-
Essex Partnership University NHS Foundation Trust
Deliver dedicated teaching on monitoring and documenting clozapine side effects.
-
Concerns raised1
Failure to account for respiratory compromise when administering laxatives
This report raised 4 other concerns. They are not shown here because they do not form part of this recurring concern.
Linked response
- Swansea Bay University Local Health Board
Stated actions An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.1
-
Swansea Bay University Local Health Board
Remind medication prescribers to select, dispense and administer medicines correctly under NICE and BNF guidance, reinforcing safe maximum-dose awareness and pharmacist dosage scrutiny.
-
Concerns raised1
Failure to prescribe and administer treatment for impacted faeces and constipation
This report raised 8 other concerns. They are not shown here because they do not form part of this recurring concern.
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
Actions and positions describe what organisations say in published responses. Implementation is not independently verified.
Data last updated 7 September 2026